Interventional cardiology: Indications for renal denervation: A balanced approach?

Nature Reviews Cardiology

Volumn 10, Issue 8, 2013, Pages 434-436

  Bakris, George L ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE; ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; SPIRONOLACTONE;

ADIPOCYTE; ALBUMINURIA; ALDOSTERONE URINE LEVEL; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CONSENSUS; ECHOCARDIOGRAPHY; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE TOLERANCE; HUMAN; KIDNEY DENERVATION; KIDNEY FUNCTION; MINOR SURGERY; OBESITY; PHEOCHROMOCYTOMA; PRESSORECEPTOR; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RESISTANT HYPERTENSION; SHORT SURVEY; SLEEP DISORDERED BREATHING; SODIUM INTAKE; SYMPATHETIC NERVE; TREATMENT INDICATION;

EID: 84881085253     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2013.85     Document Type: Short Survey

References (10)

1. Mahfoud, F. et al. Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/eht154.
2. Calhoun, D. A. et al. Resistant hypertension: Diagnosis, evaluation, and treatment. A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51, 1403-1419 (2008).
3. Sarafidis, P. A. & Bakris, G. L. State of hypertension management in the United States: Confluence of risk factors and the prevalence of resistant hypertension. J. Clin. Hypertens. (Greenwich) 10, 130-139 (2008).
4. Daugherty, S. L. et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 125, 1635-1642 (2012).
5. Sarafidis, P. A., Georgianos, P. & Bakris, G. L. Resistant hypertension - its identification and epidemiology. Nat. Rev. Nephrol. 9, 51-58 (2013).
6. Jordan, J. et al. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: Obesity and difficult to treat arterial hypertension. J. Hypertens. 30, 1047-1055 (2012).
7. Flynn, C. & Bakris, G. L. Interaction between adiponectin and aldosterone. Cardiorenal Med. 1, 96-101 (2011).
8. Briones, A. M. et al. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: Implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 59, 1069-1078 (2012).
9. Chapman, N. et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 49, 839-845 (2007).
10. Kandzari, D. E. et al. Catheter-based renal denervation for resistant hypertension: Rationale and design of the SYMPLICITY HTN-3 trial. Clin. Cardiol. 35, 528-535 (2012).